Depression, Anxiety, and Stress Relative to Swallowing Impairment in Persons with Multiple Sclerosis.


Journal

Dysphagia
ISSN: 1432-0460
Titre abrégé: Dysphagia
Pays: United States
ID NLM: 8610856

Informations de publication

Date de publication:
10 2021
Historique:
received: 20 05 2020
accepted: 27 10 2020
pubmed: 31 3 2021
medline: 25 11 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

Dysphagia and symptoms of depression, anxiety and stress are common in persons with multiple sclerosis (MS). We posited a relationship between dysphagia and increased frequency of psychological symptoms. Therefore, the aim of the present study was to examine associations between symptoms of psychological difficulties, use of emotional suppression and cognitive reappraisal strategies, and dysphagia status in persons with MS. One hundred persons with MS were prospectively assessed in multiple domains of functioning: cognitive, psychological, and dysphagia-related. Participants underwent cognitive screening with the Mini Mental State Examination and completed two psychological inventories: The depression, anxiety and stress scale (DASS)-21 and the Emotion Regulation Questionnaire. Further, they completed the dysphagia in Multiple Sclerosis questionnaire. A speech-language pathologist evaluated persons suspected of having dysphagia with the Mann Assessment of Swallowing Ability. Dysphagia was present in 29 persons with MS, and the sample was split accordingly. The two groups differed at baseline with respect to Expanded Disability Status Scale scores. There were significant between-group differences for mental health symptoms and for use of emotional regulation strategies. Accordingly, multivariate logistic regressions showed that increased symptoms of psychological stress, decreased use of cognitive reappraisal strategies, and increased indicators of emotional suppression independently predicted the presence of dysphagia. There was a clear pattern towards poorer psychological well-being in persons with dysphagia compared to those without. Psychological difficulties may contribute to the manifestation or worsening of dysphagia and should be addressed in treatment planning and future investigations. Therapeutic interventions that promote improvement in mental state alongside swallowing function may be highly beneficial.

Identifiants

pubmed: 33783621
doi: 10.1007/s00455-020-10207-x
pii: 10.1007/s00455-020-10207-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

902-909

Informations de copyright

© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Références

World Health Organization. Atlas: multiple sclerosis resources in the world 2008. Geneva: World Health Organization; 2008.
Guan X-L, Wang H, Huang H-S, Meng L. Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci. 2015;36(5):671–81.
pubmed: 25647290 doi: 10.1007/s10072-015-2067-7
Marchese-Ragona R, Restivo D, Marioni G, Ottaviano G, Masiero S, Staffieri A. Evaluation of swallowing disorders in multiple sclerosis. Neurol Sci. 2006;27(4):s335–7.
doi: 10.1007/s10072-006-0654-3
Calcagno P, Ruoppolo G, Grasso M, De Vincentiis M, Paolucci S. Dysphagia in multiple sclerosis–prevalence and prognostic factors. Acta Neurol Scand. 2002;105(1):40–3.
pubmed: 11903107 doi: 10.1034/j.1600-0404.2002.10062.x
Tassorelli C, Bergamaschi R, Buscone S, Bartolo M, Furnari A, Crivelli P, et al. Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci. 2008;29(4):360–3.
doi: 10.1007/s10072-008-1044-9
Prosiegel M, Schelling A, Wagner-Sonntag E. Dysphagia and multiple sclerosis. Int MS J. 2004;11:22–31.
pubmed: 15125813
Abraham SS, Yun PT. Laryngopharyngeal dysmotility in multiple sclerosis. Dysphagia. 2002;17(1):69–74.
pubmed: 11820388 doi: 10.1007/s00455-001-0103-7
Boeschoten RE, Braamse AM, Beekman AT, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.
pubmed: 28017241 doi: 10.1016/j.jns.2016.11.067
Gold SM, Irwin MR. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin N Am. 2009;29(2):309–20.
doi: 10.1016/j.iac.2009.02.008
Feinstein A, Roy P, Lobaugh N, Feinstein K, O’connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology. 2004;62(4):586–90.
pubmed: 14981175 doi: 10.1212/01.WNL.0000110316.12086.0C
Group GC. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler J. 2005;11(3):328–37.
doi: 10.1191/1352458505ms1162oa
Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: a meta-analytic review. Clin Psychol Rev. 2010;30(2):217–37.
pubmed: 20015584 doi: 10.1016/j.cpr.2009.11.004
Gross JJ. Handbook of emotion regulation. New York: Guilford Publications; 2013.
Fernandes AM, Duprat Ade C, Eckley CA, Silva L, Ferreira RB, Tilbery CP. Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity? Braz J Otorhinolaryngol. 2013;79(4):460–5.
pubmed: 23929146 doi: 10.5935/1808-8694.20130082
Folks DG, Kinney FC. The role of psychological factors in gastrointestinal conditions: a review pertinent to DSM-IV. Psychosomatics. 1992;33(3):257–70.
pubmed: 1410199 doi: 10.1016/S0033-3182(92)71964-1
Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia. 2002;17(2):139–46.
pubmed: 11956839 doi: 10.1007/s00455-001-0113-5
Baijens LW, Koetsenruijter K, Pilz W. Diagnosis and treatment of phagophobia: a review. Dysphagia. 2013;28(2):260–70.
pubmed: 23446813 doi: 10.1007/s00455-013-9454-0
Verdonschot RJ, Baijens LW, Serroyen JL, Leue C, Kremer B. Symptoms of anxiety and depression assessed with the Hospital Anxiety and Depression Scale in patients with oropharyngeal dysphagia. J Psychosom Res. 2013;75(5):451–5.
pubmed: 24182634 doi: 10.1016/j.jpsychores.2013.08.021
Verdonschot RJ, Baijens LW, Vanbelle S, van de Kolk I, Kremer B, Leue C. Affective symptoms in patients with oropharyngeal dysphagia: a systematic review. J Psychosom Res. 2017;97:102–10.
pubmed: 28606489 doi: 10.1016/j.jpsychores.2017.04.006
Tarameshlu M, Azimi AR, Ghelichi L, Ansari NN. Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Med J Islam Repub Iran. 2017;31:133.
pubmed: 29951433 pmcid: 6014781 doi: 10.14196/mjiri.31.133
Poorjavad M, Derakhshandeh F, Etemadifar M, Soleymani B. Associated factors with swallowing disorders in patients with multiple sclerosis. J Isfahan Med School. 2010;28(104):40–6.
Solaro C, Rezzani C, Trabucco E, Amato M, Zipoli V, Portaccio E, et al. Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). J Neurol Sci. 2013;331(1–2):94–7.
pubmed: 23747002 doi: 10.1016/j.jns.2013.05.020
De Pauw A, Dejaeger E, D’hooghe B, Carton H. Dysphagia in multiple sclerosis. Clin Neurol Neurosurg. 2002;104(4):345–51.
pubmed: 12140103 doi: 10.1016/S0303-8467(02)00053-7
Thomas FJ, Wiles C. Dysphagia and nutritional status in multiple sclerosis. J Neurol. 1999;246(8):677–82.
pubmed: 10460444 doi: 10.1007/s004150050431
Manor Y, Balas M, Giladi N, Mootanah R, Cohen JT. Anxiety, depression and swallowing disorders in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(6):453–6.
pubmed: 19071054 doi: 10.1016/j.parkreldis.2008.11.005
Han M, Ohnishi H, Nonaka M, Yamauchi R, Hozuki T, Hayashi T, et al. Relationship between dysphagia and depressive states in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):437–9.
pubmed: 21458355 doi: 10.1016/j.parkreldis.2011.03.006
Lin BM, Starmer HM, Gourin CG. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy. Laryngoscope. 2012;122(7):1518–25.
pubmed: 22467530 doi: 10.1002/lary.23312
Holland G, Jayasekeran V, Pendleton N, Horan M, Jones M, Hamdy S. Prevalence and symptom profiling of oropharyngeal dysphagia in a community dwelling of an elderly population: a self-reporting questionnaire survey. Dis Esophagus. 2011;24(7):476–80.
pubmed: 21385285 doi: 10.1111/j.1442-2050.2011.01182.x
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
pubmed: 1202204 doi: 10.1016/0022-3956(75)90026-6
Ansari NN, Naghdi S, Hasson S, Valizadeh L, Jalaie S. Validation of a Mini-Mental State Examination (MMSE) for the Persian population: a pilot study. Appl Neuropsychol. 2010;17(3):190–5.
pubmed: 20799110 doi: 10.1080/09084282.2010.499773
Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther. 1997;35(1):79–89.
pubmed: 9009048 doi: 10.1016/S0005-7967(96)00068-X
Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess. 1998;10(2):176.
doi: 10.1037/1040-3590.10.2.176
Asghari A, Saed F, Dibajnia P. Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J psychol. 2008;2(2):82–102.
Gloster AT, Rhoades HM, Novy D, Klotsche J, Senior A, Kunik M, et al. Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord. 2008;110(3):248–59.
pubmed: 18304648 pmcid: 2709995 doi: 10.1016/j.jad.2008.01.023
Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44(2):227–39.
pubmed: 16004657 doi: 10.1348/014466505X29657
Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42(Pt 2):111–31.
pubmed: 12828802 doi: 10.1348/014466503321903544
Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Iran Psychol. 2005;4(1):299–313.
Samani S, Joukar B. A study on the reliability and validity of the short form of the depression anxiety stress scale (DASS-21). 2007.
Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Person Soc Psychol. 2003;85(2):348.
doi: 10.1037/0022-3514.85.2.348
Hasani J. Persian version of the emotion regulation questionnaire: factor structure, reliability and validity. Int J Behav Sci. 2016;10(3):156–61.
Bergamaschi R, Crivelli P, Rezzani C, Patti F, Solaro C, Rossi P, et al. The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis. J Neurol Sci. 2008;269(1–2):49–53.
pubmed: 18280504 doi: 10.1016/j.jns.2007.12.021
Jafari Z, Shahbodaghi MR, Maroufizadeh S, Moghadasi AN. Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis. Iran J Neurol. 2018;17(3):99.
pubmed: 30886675 pmcid: 6420693
Asadollahpour F, Mehri A, Khatoonabadi A, Mohammadzaheri F, Ebadi A. Validation of the Persian version of the dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis. J Res Med Sci J Isfahan Univ Med Sci. 2019;24:52.
Mann G. MASA: the Mann assessment of swallowing ability. Boston: Cengage Learning; 2002.
González-Fernández M, Sein MT, Palmer JB. Clinical experience using the Mann assessment of swallowing ability for identification of patients at risk for aspiration in a mixed-disease population. Am J Speech-Lang Pathol. 2011;20:331.
pubmed: 21813822 doi: 10.1044/1058-0360(2011/10-0082)
Mennin DS, Holaway RM, Fresco DM, Moore MT, Heimberg RG. Delineating components of emotion and its dysregulation in anxiety and mood psychopathology. Behav Ther. 2007;38(3):284–302.
pubmed: 17697853 doi: 10.1016/j.beth.2006.09.001
Campbell-Sills L, Barlow DH. Incorporating emotion regulation into conceptualizations and treatments of anxiety and mood disorders. In: Gross JJ, editor. Handbook of emotion regulation. New York: Guilford Press; 2007. p. 2.
Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialog Clin Neurosci. 2011;13(1):7.
doi: 10.31887/DCNS.2011.13.1/wkaton
Kisely S, Smith M, Lawrence D, Maaten S. Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatry. 2005;187(6):552–8.
pubmed: 16319408 doi: 10.1192/bjp.187.6.552
Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665–73.
pubmed: 18840840 pmcid: 2853806 doi: 10.1001/jama.300.14.1665
Naragon-Gainey K, McMahon TP, Chacko TP. The structure of common emotion regulation strategies: a meta-analytic examination. Psychol Bull. 2017;143(4):384.
pubmed: 28301202 doi: 10.1037/bul0000093

Auteurs

Zahra Sadeghi (Z)

Department of Speech Therapy, University of Social Welfare and Rehabilitation Sciences, Koodakyar Avenue, Evin, Tehran, Iran.

Zahra Sadat Ghoreishi (ZS)

Department of Speech Therapy, University of Social Welfare and Rehabilitation Sciences, Koodakyar Avenue, Evin, Tehran, Iran. za.ghoreyshi@uswr.ac.ir.

Heather Flowers (H)

School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada.

Parvaneh Mohammadkhani (P)

Department of Clinical Psychology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Fereshteh Ashtari (F)

Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Mehdi Noroozi (M)

Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH